Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Stereotactic body radiotherapy safe, effective for low to intermediate risk prostate cancer

Stereotactic body radiotherapy induced high rates of biochemical control and low rates of severe toxicity among men with low- or intermediate-risk prostate cancer, according to results of a retrospective study published in JAMA Oncology.

The results suggest that SBRT, which cuts treatment duration to 4 or 5 days, should be considered a standard option for these men.

To read the full article: https://tinyurl.com/y47wup2d

source: Amar Kishan - Healio